134 related articles for article (PubMed ID: 19875344)
1. Prevalence of dyslipidemia in adults with cystic fibrosis.
Rhodes B; Nash EF; Tullis E; Pencharz PB; Brotherwood M; Dupuis A; Stephenson A
J Cyst Fibros; 2010 Jan; 9(1):24-8. PubMed ID: 19875344
[TBL] [Abstract][Full Text] [Related]
2. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of coronary heart disease and risk factors in an urban Indian population: Jaipur Heart Watch-2.
Gupta R; Gupta VP; Sarna M; Bhatnagar S; Thanvi J; Sharma V; Singh AK; Gupta JB; Kaul V
Indian Heart J; 2002; 54(1):59-66. PubMed ID: 11999090
[TBL] [Abstract][Full Text] [Related]
4. Serum lipid profiles including non-high density lipoprotein cholesterol levels in Turkish school-children.
Uçar B; Kiliç Z; Dinleyici EC; Colak O; Güneş E
Anadolu Kardiyol Derg; 2007 Dec; 7(4):415-20. PubMed ID: 18065339
[TBL] [Abstract][Full Text] [Related]
5. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
De Boeck K; Weren M; Proesmans M; Kerem E
Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
[TBL] [Abstract][Full Text] [Related]
6. Correlation of dyslipidemia with waist to height ratio, waist circumference, and body mass index in Iranian adults.
Chehrei A; Sadrnia S; Keshteli AH; Daneshmand MA; Rezaei J
Asia Pac J Clin Nutr; 2007; 16(2):248-53. PubMed ID: 17468079
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of dyslipidemia in rural Thai adults: an epidemiologic study in Khon Kaen province.
Pongchaiyakul C; Pongchaiyakul C; Pratipanawatr T
J Med Assoc Thai; 2005 Aug; 88(8):1092-7. PubMed ID: 16404837
[TBL] [Abstract][Full Text] [Related]
8. Triglyceride profile in dyslipidaemia of type 2 diabetes mellitus.
Khan SR; Ayub N; Nawab S; Shamsi TS
J Coll Physicians Surg Pak; 2008 May; 18(5):270-3. PubMed ID: 18541079
[TBL] [Abstract][Full Text] [Related]
9. Lipid and lipoprotein profiles and prevalence of dyslipidemia in Mexican adolescents.
Posadas-Sánchez R; Posadas-Romero C; Zamora-González J; Mendoza-Pérez E; Cardoso-Saldaña G; Yamamoto-Kimura L
Metabolism; 2007 Dec; 56(12):1666-72. PubMed ID: 17998019
[TBL] [Abstract][Full Text] [Related]
10. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of dyslipidaemia in apparently healthy professionals in Asaba, South South Nigeria.
Odenigbo CU; Oguejiofor OC; Odenigbo UM; Ibeh CC; Ajaero CN; Odike MA
Niger J Clin Pract; 2008 Dec; 11(4):330-5. PubMed ID: 19320405
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and control of dyslipidemia among persons with diabetes in the United States.
Jacobs MJ; Kleisli T; Pio JR; Malik S; L'Italien GJ; Chen RS; Wong ND
Diabetes Res Clin Pract; 2005 Dec; 70(3):263-9. PubMed ID: 15890427
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004.
Ghandehari H; Kamal-Bahl S; Wong ND
Am Heart J; 2008 Jul; 156(1):112-9. PubMed ID: 18585505
[TBL] [Abstract][Full Text] [Related]
15. Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Study.
Kershnar AK; Daniels SR; Imperatore G; Palla SL; Petitti DB; Pettitt DJ; Marcovina S; Dolan LM; Hamman RF; Liese AD; Pihoker C; Rodriguez BL
J Pediatr; 2006 Sep; 149(3):314-9. PubMed ID: 16939739
[TBL] [Abstract][Full Text] [Related]
16. Dyslipidaemia and hypertension among adults with diabetes in rural Uganda.
Kamara NT; Asiimwe S
Trop Doct; 2010 Jan; 40(1):41-2. PubMed ID: 20075425
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of dyslipidemia in the Iraqi adult population.
Mula-Abed WA; Chilmeran SK
Saudi Med J; 2007 Dec; 28(12):1868-74. PubMed ID: 18060219
[TBL] [Abstract][Full Text] [Related]
18. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W
Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
[TBL] [Abstract][Full Text] [Related]
19. Lifetime risk for developing dyslipidemia: the Framingham Offspring Study.
Cobain MR; Pencina MJ; D'Agostino RB; Vasan RS
Am J Med; 2007 Jul; 120(7):623-30. PubMed ID: 17602937
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
